RANIERI, JESSICA
 Distribuzione geografica
Continente #
NA - Nord America 1.439
EU - Europa 780
AS - Asia 205
OC - Oceania 10
AF - Africa 5
Totale 2.439
Nazione #
US - Stati Uniti d'America 1.436
RU - Federazione Russa 307
PL - Polonia 168
IE - Irlanda 91
SE - Svezia 84
CN - Cina 60
IT - Italia 60
SG - Singapore 53
HK - Hong Kong 42
DE - Germania 23
FI - Finlandia 21
IN - India 18
GB - Regno Unito 13
JO - Giordania 11
AU - Australia 10
BE - Belgio 9
TR - Turchia 8
VN - Vietnam 7
CI - Costa d'Avorio 5
ID - Indonesia 4
CA - Canada 3
FR - Francia 2
KR - Corea 2
LT - Lituania 1
NL - Olanda 1
Totale 2.439
Città #
Santa Clara 441
Warsaw 166
Fairfield 131
Chandler 108
Dublin 91
Ashburn 77
Seattle 67
Wilmington 60
Woodbridge 60
Cambridge 57
Ann Arbor 52
Houston 49
Singapore 43
Beijing 37
Altamura 28
Lawrence 26
Hong Kong 24
Princeton 23
Bremen 21
Buffalo 21
Mumbai 18
Florence 14
Boston 12
Boardman 11
Medford 11
Shanghai 11
Melbourne 10
New York 10
Brussels 9
Izmir 8
Dong Ket 6
Falls Church 6
San Diego 6
Abidjan 5
Norwalk 5
Old Bridge 5
Avigliano 4
Jakarta 4
Ferriere 3
Jacksonville 3
Andover 2
Bastia umbra 2
Laurel 2
London 2
Radomsko 2
Redmond 2
Toronto 2
Washington 2
Brescia 1
Brooklyn 1
Chiswick 1
Hangzhou 1
Hanoi 1
Hillsboro 1
Kent 1
Kilburn 1
Los Angeles 1
New Bedfont 1
Ottawa 1
Phoenix 1
Shijiazhuang 1
Totale 1.772
Nome #
Role of MicroRNA Profile Modifications in Hepatitis C Virus-Related Mixed Cryoglobulinemia 268
Combined treatment with antiviral therapy and rituximab in patients with mixed cryoglobulinemia: review of the literature and report of a case using direct antiviral agents-based antihepatitis C virus therapy 165
Efficacy of low-dose rituximab for the treatment of mixed cryoglobulinemia vasculitis: Phase II clinical trial and systematic review 163
Host genetic determinants in HCV-related mixed cryoglobulinemia 154
A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection 150
Long-term effect of HCV eradication in patients with mixed cryoglobulinemia: A prospective, controlled, open-label, cohort study. 141
Host genetic determinants in HCV-related mixed cryoglobulinemia 135
Triple antiviral therapy in hepatitis C virus infection with or without mixed cryoglobulinaemia: A prospective, controlled pilot study. 121
Host genetic determinants in HCV-related mixed cryoglobulinemia 111
VALUE OF IL28B GENOTYPING IN PATIENTS WITH HCV-RELATED MIXED CRYOGLOBULINEMIA: RESULTS OF A LARGE, PROSPECTIVE STUDY 109
microRNA PROFILE MODIFICATIONS IN HEPATITIS C VIRUS-RELATED MIXED CRYOGLOBULINEMIA 107
Could the presence of Mixed Cryoglobulinemia influence the outcome of standard peg-IFN plus ribavirin anti-HCV therapy? 92
Il polimorfismo dell'interleuchina 28B come predittore di risposta in pazienti con crioglobulinemia mista HCV-correlata 88
Response to IFN-based antiviral therapy and long term effect of HCV eradication in Mixed Cryoglobulinemia, with or without symptoms: a prospective, controlled, open-label, long term, cohort study 88
ETIOLOGICAL THERAPY IN HCV-RELATED MIXED CRYOGLOBULINEMIA SYNDROME: THE ROLE OF IL28B GENOTYPE AS PREDICTOR OF RESPONSE 87
Genetic determinants in Hepatitis C Virus-associated mixed cryoglobulinemia: role of polymorphic variants of BAFF promoter and Fc-gamma receptors 83
Safety and effectiveness of boceprevir triple therapy in patients with mixed cryoglobulinemia 82
Mixed cryoglobulinemia syndrome is a negative prognostic factor in the standard of care (Peg-IFN+ribavirin) anti-HCV therapy 80
IL28B polymorphism as predictor of response to anti-HCV terapy in HCV-related mixed cryoglobulinemia syndrome 76
Long-term outcome of HCV-related mixed cryoglobulinemia in patients achieving sustained viral sustained viral response (SVR) after antiviral therapy 73
IL28B POLYMORPHISM AS PREDICTOR OF RESPONSE TO ANTI-HCV THERAPY IN HCV-RELATED MIXED CRYOGLOBULINEMIA SYNDROME 70
Totale 2.443
Categoria #
all - tutte 6.348
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.348


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020176 0 0 0 0 0 0 35 33 35 45 25 3
2020/2021182 16 11 2 25 11 17 11 11 22 30 18 8
2021/2022172 2 15 10 10 8 10 4 13 7 6 31 56
2022/2023452 35 65 29 45 40 85 55 30 51 1 12 4
2023/2024124 3 21 23 6 3 19 1 31 3 2 5 7
2024/2025928 51 114 73 166 357 167 0 0 0 0 0 0
Totale 2.443